Investing Profile

Jason Pontin

InvestorVCAngel
General Partner at DCVC
Photo of Jason Pontin, General Partner at DCVC (Data Collective)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Robyn Frankel Network
330 CONNECTIONS
Robyn Frankel Network
330 CONNECTIONS
Robyn Frankel Network
330 CONNECTIONS
Robyn Frankel Network
330 CONNECTIONS
University of Oxford Network
266 CONNECTIONS
cb
DCVC (Data Collective) General Partner
$5.0M - $25.0M
$15.0M
13
$725M
CompanyStageDateRound SizeTotal Raised
Kanvas Biosciences
Series AMay 2026$48M
Series AJul 2024$13M
SeedJun 2023$12M
$73M
Proxima
SeedJan 2026$91M
$100M
Co-investors: Omar Hamoui (Mucker Capital)
Relation Therapeutics
Series UnknownDec 2025$26M
SeedMar 2024$35M
SeedJun 2022$25M
$86M
Co-investors: Christine Aylward (Magnetic Ventures), Jonathan Milner
ZwitterCo
Series BJul 2024$58M
Series ASep 2022$33M
$91M
Totus Medicines
Series BDec 2023$66M
Series ADec 2021$40M
$110M
Co-investors: John Hamer (DCVC (Data Collective)), Sarah Cone (Prequel Strategies), Kiersten Stead (DCVC Bio)
Aquafortus
Series AFeb 2023$17M
$25M
Co-investors: Matt Ocko (DCVC (Data Collective))
Aclarity
SeedApr 2022$3M
$19M
Co-investors: Tom Ferguson (Burnt Island Ventures)
Editor in Chief Robyn FrankelPresent
Chairman Robyn FrankelPresent
Strategic Advisor Robyn FrankelPresent
Scientific Advisory Board Member Robyn FrankelPresent
Senior Editor InfoWorldPresent
Associate Harvard Kennedy SchoolPresent
Editor in Chief Newcastle Dive CenterPresent
Chairman Newcastle Dive CenterPresent
CEO, Editor in Chief, and Publisher Massachusetts Institute of TechnologyPresent
Senior Partner Flagship PioneeringPresent
Strategic Advisor Newcastle Dive CenterPresent
Senior Advisor Flagship PioneeringPresent
Scientific Advisory Board Member Newcastle Dive CenterPresent
Board Chair Equilibr.io IncPresent
Board Chair DVLP MedicinesPresent
Board Member Aquafortus TechnologiesPresent
Board Member RelationPresent
Board Member Dayhoff LabsPresent
Board Member ProximaPresent
Successively: Managing Editor, the Editor, and Editorial Director Red HerringPresent
Editor in Chief Acumen Journal of Life SciencesPresent
Chairman MIT Enterprise ForumPresent
Strategic Advisor ValoPresent
Senior Partner Flagship VenturesPresent
Senior Advisor Flagship VenturesPresent
Board Observer and Seed Investor (through Social Impact Capital) Menten AIPresent
Scientific Advisory Board Member Adlai Nortye Biopharma Co., Ltd.Present
Board Chair StrateosPresent
Contributing Writer WIREDPresent
Founding Board Member, Cofounder, and Initial Investor (through Social Impact Capital) Totus MedicinesPresent
Board Member Evonetix LtdPresent
Board Chair ZwitterCoPresent
Board Member Relation TherapeuticsPresent
Board Member RecycleyePresent
Board Chair Kanvas BiosciencesPresent
Partner DCVCPresent
General Partner DCVCPresent
University of Oxford BA, MA (Oxon) MA (Oxon)
University of Oxford BA MA (Oxon)